RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,228,270 | -21.4% | 1,568,753 | 0.0% | 0.52% | 0.0% |
Q1 2024 | $13,020,649 | -24.6% | 1,568,753 | 0.0% | 0.52% | -35.3% |
Q4 2023 | $17,271,970 | +30.9% | 1,568,753 | 0.0% | 0.80% | -5.4% |
Q3 2023 | $13,193,212 | -33.0% | 1,568,753 | 0.0% | 0.85% | -20.0% |
Q2 2023 | $19,703,537 | -23.7% | 1,568,753 | 0.0% | 1.06% | -26.1% |
Q1 2023 | $25,837,362 | +10.2% | 1,568,753 | 0.0% | 1.43% | +5.3% |
Q4 2022 | $23,437,170 | -33.2% | 1,568,753 | 0.0% | 1.36% | -24.1% |
Q3 2022 | $35,093,000 | +33.6% | 1,568,753 | 0.0% | 1.79% | +25.7% |
Q2 2022 | $26,277,000 | -44.0% | 1,568,753 | 0.0% | 1.43% | -6.4% |
Q1 2022 | $46,953,000 | -2.3% | 1,568,753 | +0.3% | 1.52% | +31.3% |
Q4 2021 | $48,036,000 | -7.2% | 1,564,173 | -4.7% | 1.16% | -5.5% |
Q3 2021 | $51,756,000 | -22.6% | 1,641,497 | -10.1% | 1.23% | -9.8% |
Q2 2021 | $66,845,000 | +23.3% | 1,826,876 | +16.5% | 1.36% | -37.7% |
Q1 2021 | $54,222,000 | -27.6% | 1,568,486 | -12.9% | 2.19% | -39.1% |
Q4 2020 | $74,870,000 | -2.4% | 1,801,490 | 0.0% | 3.59% | -0.3% |
Q3 2020 | $76,725,000 | – | 1,801,490 | – | 3.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 5,998,574 | $75,342,089 | 6.58% |
Nextech Invest Ltd. | 948,659 | $11,915,157 | 4.05% |
MPM BioImpact LLC | 1,354,368 | $17,010,862 | 3.42% |
Finepoint Capital LP | 701,570 | $8,811,719 | 3.05% |
SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $350,486,335 | 2.67% |
EcoR1 Capital, LLC | 4,163,824 | $52,297,629 | 1.28% |
BVF INC/IL | 3,120,521 | $39,193,744 | 1.09% |
Integral Health Asset Management, LLC | 700,000 | $8,792,000 | 1.09% |
Boxer Capital, LLC | 1,819,132 | $22,848 | 1.06% |
Alphabet Inc. | 1,568,753 | $19,703,537 | 1.06% |